Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
NCT02639702Phase 4Recruiting
- Sponsor
- Center for Addiction and Mental Health
- Start
- Oct 2016
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in schizophrenia, schizoaffective disorder, sponsored by Center for Addiction and Mental Health. Started Oct 2016; status: recruiting.
02
Drugs
clozapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02639702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639702.